![α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb | Acta Neuropathologica Communications | Full Text α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40478-019-0859-3/MediaObjects/40478_2019_859_Fig1_HTML.png)
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb | Acta Neuropathologica Communications | Full Text
![Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species | Scientific Reports Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-38271-2/MediaObjects/41598_2018_38271_Fig1_HTML.png)
Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species | Scientific Reports
![A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS](https://www.pnas.org/content/pnas/114/6/E1009/F6.large.jpg)
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
![A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS](https://www.pnas.org/content/pnas/114/6/E1009/F10.large.jpg)
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
![Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts | Nature Communications Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-13564-w/MediaObjects/41467_2019_13564_Fig1_HTML.png)
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts | Nature Communications
![Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies - ScienceDirect Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969996117301705-gr1.jpg)
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies - ScienceDirect
![Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. - Abstract - Europe PMC Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6004926/bin/jpd-8-jpd171248-g001.jpg)
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. - Abstract - Europe PMC
![Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/321342798/figure/fig2/AS:566064615313409@1511971729998/Characterization-of-SNpc-intraneuronal-a-Synuclein-accumulations-a-Double-labeling.png)
Characterization of SNpc intraneuronal α-Synuclein accumulations. (a)... | Download Scientific Diagram
![Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease | Frontiers in Molecular Neuroscience Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease | Frontiers in Molecular Neuroscience](https://www.frontiersin.org/files/Articles/496177/fnmol-12-00299-HTML/image_m/fnmol-12-00299-g001.jpg)
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease | Frontiers in Molecular Neuroscience
![Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases - IOS Press Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases - IOS Press](https://content.iospress.com/media/jpd/2015/5-2/jpd-5-2-jpd150543/jpd-5-2-jpd150543-g002.jpg?width=755)
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases - IOS Press
![Frontiers | In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons | Cell and Developmental Biology Frontiers | In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/559791/fcell-08-559791-HTML/image_m/fcell-08-559791-g001.jpg)
Frontiers | In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons | Cell and Developmental Biology
![Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril | Scientific Reports Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep30891/MediaObjects/41598_2016_Article_BFsrep30891_Fig1_HTML.jpg)